Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-quadruplex (G4) DNA structures are non-canonical, four-stranded secondary structures formed in guanine-rich sequences through Hoogsteen hydrogen bonding (MDPI, 2021; NIH, 2023). These structures are highly prevalent in the promoter regions of key oncogenes such as MYC, BCL2, and KRAS, where they often exist at the junction between the G4 motif and the flanking duplex DNA (MDPI, 2017; NIH, 2021). The G4-duplex junction represents a unique structural interface that can be specifically targeted by small molecules to modulate gene expression (NIH, 2021). Stabilization of these structures typically acts as a transcriptional repressor, preventing the binding of transcription factors or the progression of RNA polymerase, thereby downregulating oncogene expression (IntechOpen, 2013; MDPI, 2017). Beyond transcription, G4 structures at these junctions are involved in DNA replication and genome stability, making them attractive targets for cancer therapy (NIH, 2013; NIH, 2021). Drugs like CX-5461 and various G4 ligands aim to stabilize these structures to induce replication stress and apoptosis in cancer cells, often exploiting synthetic lethal relationships in DNA repair-deficient tumors (PNAS, 2012; NIH, 2021).
Stabilization of G-quadruplex structures at promoter regions to inhibit oncogene transcription, induction of replication stress, and inhibition of telomerase activity (NIH, 2023; MDPI, 2017).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-quadruplex DNA structure at G4-duplex junction (G4-duplex junction).